Medication and monitoring in palliative sedation therapy: A systematic review and quality assessment of published guidelines

Journal of Pain and Symptom Management

Volumn 49, Issue 4, 2015, Pages 734-746

  Schildmann, Eva Katharina ^a   Schildmann, Jan ^b   Kiesewetter, Isabel ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

drug monitoring; Palliative sedation; practice guidelines; quality assurance

Indexed keywords

LEVOMEPROMAZINE; MIDAZOLAM; PHENOBARBITAL; PROPOFOL; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT;

DRUG MONITORING; HUMAN; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; SEDATION; SYSTEMATIC REVIEW; HEALTH CARE QUALITY; PHYSIOLOGIC MONITORING; PROCEDURES;

GUIDELINES AS TOPIC; HUMANS; HYPNOTICS AND SEDATIVES; MONITORING, PHYSIOLOGIC; PALLIATIVE CARE; QUALITY ASSURANCE, HEALTH CARE;

EID: 84925934331     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2014.08.013     Document Type: Review

References (27)

1. A. de Graeff, and M. Dean Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards J Palliat Med 10 2007 67 85
2. N.I. Cherny, and R.K. Portenoy Sedation in the management of refractory symptoms: guidelines for evaluation and treatment J Palliat Care 10 1994 31 38
3. N.I. Cherny, and L. Radbruch European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care Palliat Med 23 2009 581 593
4. M.M. Dean, V. Cellarius, B. Henry, D. Oneschuk, L. Librach Canadian Society Of Palliative Care Physicians Taskforce SL Framework for continuous palliative sedation therapy in Canada J Palliat Med 15 2012 870 879
5. Z.D. Schuman, and J. Abrahm Implementing institutional change: an institutional case study of palliative sedation J Palliat Med 8 2005 666 676
6. E. Schildmann, and J. Schildmann Palliative sedation therapy: a systematic literature review and critical appraisal of available guidance on indication and decision-making J Palliat Med 17 2014 601 611
7. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
8. Agree Next Steps Consortium. The AGREE II Instrument. 2009. Available at: http://www.agreetrust.org. Accessed August 10, 2014.
9. J. Legemaate, M. Verkerk, E. van Wijlick, and A. de Graeff Palliative sedation in the Netherlands: starting-points and contents of a national guideline Eur J Health Law 14 2007 61 73
10. T. Morita, S. Bito, Y. Kurihara, and Y. Uchitomi Development of a clinical guideline for palliative sedation therapy using the Delphi method J Palliat Med 8 2005 716 729
11. Hospice and Palliative Care Federation of Massachusetts Palliative sedation protocol: A report of the standards and best practices committee 2004 Hospice and Palliative Care Federation of Massachusetts Norwood, MA
12. T.C. Braun, N.A. Hagen, and T. Clark Development of a clinical practice guideline for palliative sedation J Palliat Med 6 2003 345 350
13. T.W. Kirk, and M.M. Mahon National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients J Pain Symptom Manage 39 2010 914 923
14. L. Gurschick, D.K. Mayer, and L.C. Hanson Palliative sedation. An analysis of international guidelines and position statements Am J Hosp Palliat Care 2014 Mar 7 [Epub ahead of print]
15. D. Strech, and J. Schildmann Quality of ethical guidelines and ethical content in clinical guidelines. The example of end-of life decision making J Med Ethics 37 2011 390 396
16. P. Claessens, J. Menten, P. Schotsmans, and B. Broeckaert Palliative sedation: a review of the research literature J Pain Symptom Manage 36 2008 310 333
17. K. McWilliams, P.W. Keeley, and E.T. Waterhouse Propofol for terminal sedation in palliative care: a systematic review J Palliat Med 13 2010 73 76
18. D. Aretha, E.S. Panteli, P. Kiekkas, and M. Karanikolas Patient and/or family controlled palliative sedation with midazolam for intractable symptom control: a case series Cases J 2 2009 136
19. C.M. Herndon, and E. Zimmerman High-dose propofol drip for palliative sedation: a case report Am J Hosp Palliat Care 25 2008 492 495
20. G. Porzio, F. Aielli, and L. Verna Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study Support Care Cancer 18 2010 77 81
21. A.L. Burke, P.L. Diamond, J. Hulbert, J. Yeatman, and E.A. Farr Terminal restlessness - its management and the role of midazolam Med J Aust 155 1991 485 487
22. H. Kohara, H. Ueoka, H. Takeyama, T. Murakami, and T. Morita Sedation for terminally ill patients with cancer with uncontrollable physical distress J Palliat Med 8 2005 20 25
23. S. Lundström, U. Zachrisson, and C.J. Fürst When nothing helps: propofol as sedative and antiemetic in palliative cancer care J Pain Symptom Manage 30 2005 570 577
24. J.A.C. Rietjens, A. van der Heide, and A.M. Vrakking Physician reports of terminal sedation without hydration or nutrition for patients nearing death in the Netherlands Ann Intern Med 141 2004 178 185
25. T. Brinkkemper, A.M. van Norel, and K.M. Szadek The use of observational scales to monitor symptom control and depth of sedation in patients requiring palliative sedation: a systematic review Palliat Med 27 2013 54 57
26. J.J. Arevalo, T. Brinkkemper, and A. van der Heide Palliative sedation: reliability and validity of sedation scales J Pain Symptom Manage 44 2012 704 714
27. T. Morita, J. Tsunoda, S. Inoue, and S. Chihara Improved accuracy of physicians' survival prediction for terminally ill cancer patients using the Palliative Prognostic Index Palliat Med 15 2001 419 424